Cite
HARVARD Citation
Sacramento, C. et al. (2021). In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. Journal of antimicrobial chemotherapy. pp. 1874-1885. [Online].